1 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Thromboinflammation: new trials by email Literature Review of Thromboinflammation trials Research Report on Thromboinflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| "IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ" Anakinra 100Mg/0.67Ml Inj Syringe - Pancreatic Transplant | Phase 1 / Phase 2 | Recruiting | Nantes University Hospital | 15 | 2026-10-07 | 2026-10-13 |
| Safely Quenching Complement in Stroke Survivors Pegcetacoplan Injection [Empaveli] - Acute Ischemic Stroke, Cerebral Infarction | Phase 1 | Not yet recruiting | Columbia University | 20 | 2026-10-01 | 2026-04-29 |
Cerebral Infarction (1) · Ischemic Stroke (1) · Reperfusion Injury (1)
Blood Coagulation Disorders (2) · Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Thrombosis (2) · Vascular Diseases (2) · Brain Diseases (1) · Brain Infarction (1) · Brain Ischemia (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1)
Interleukin 1 Receptor Antagonist Protein (1) · pegcetacoplan (1)
Columbia University (1) · Nantes University Hospital (1)
France (1)